Top compounds associated with response to C18orf21


Feature Type Standardized
Nominal ANOVA
mRNA FK866 GDSC1000 pan-cancer AAC 0.094 0.003
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA tandutinib CTRPv2 pan-cancer AAC 0.11 0.003
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.099 0.003
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.088 0.004
mRNA PIK-93 GDSC1000 pan-cancer AAC 0.085 0.004
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.004
mRNA XL765 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.098 0.004
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.096 0.004
Download CSV